A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1225-1232

  Dubé, Michael P ^c   Sattler, Fred R ^a   Torriani, Francesca J ^c   See, Darryl ^c   Havlir, Diane V ^c   Kemper, Carol A ^c   Dezfuli, Massoud G ^b   Bozzette, Samuel A ^c   Bartok, Angie E ^c   Leedom, John M ^c   Tilles, Jeremiah G ^c   McCutchan, J Allen ^c  

^a LAC USC MEDICAL CENTER   (United States)

^b Axminster Medical Group   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOBACTERIUM INTRACELLULARE AVIUM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SURVIVAL;

EID: 9844260505     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514116     Document Type: Article

References (14)

1. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne DA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992:165:1082-5.
2. Chan ISF, Neaton JD, Saravolatz LD, Crane LR, Osterberger J. Frequencies of opportunistic diseases prior to death among HIV-infected persons. AIDS 1995;9:1145-51.
3. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. Am Rev Respir Dis 1992;146:285-9.
4. Jacobson MA, Hopewell PC, Yajko DM, et al. Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 1991;164:994-8.
5. Ives DV, Davis RB, Currier JS. Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. AIDS 1995;9:261-6.
6. Chin DP, Reingold AL, Stone EN, et al. The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients - a prospective study. J Infect Dis 1994;170:578-4.
7. Horsburgh CR, Metchock B, Gordon SM, Havlik JA, McGowan JE, Thompson SE. Predictors of survival in patients with AIDS and dissem-inated Mycobacterium avium complex disease. J Infect Dis 1994;170: 573-7.
8. Chiu J, Nussbaum J, Bozzette S, et al. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann Intern Med 1990;113:358-61.
9. Kemper CA, Meng TC, Nussbaum J, et al. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. Ann Intern Med 1992;116:466-72.
10. Shafrin SD, Singer J, Zarowney DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med 1996;335:377-83.
11. Chaisson RE, Benson CA, Dubé MP, et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. Ann Intern Med 1994;121:905-11.
12. Dautzenberg B, Truffot C, Legris S, et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis 1991;144:564-8.
13. Klemens SP, DeStefano MS, Cynamon MH. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother 1992;36:2413-7.
14. Rastogi N, Labrousse V. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. Antimicrob Agents Chemother 1991;35:462-70.